Zemplar (Paricalcitol Injection) and Hepatobiliary dysfunction
Result of checking the interaction of drug Zemplar (Paricalcitol Injection) and disease Hepatobiliary dysfunction for safety when used together.
When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.
Consumer:Paricalcitol is metabolized by the liver. Parent compound and metabolites are primarily eliminated by in the bile and feces. Paricalcitol metabolites have not been characterized or identified. Metabolic and therapeutic activity of paricalcitol may be altered in patients with hepatic impairment. Therapy with paricalcitol should be administered cautiously in patients with hepatobiliary dysfunction. Clinical monitoring of hepatobiliary function, parathyroid hormone and calcium levels is recommended.
- "Product Information. Zemplar (paricalcitol)." Abbott Pharmaceutical, Abbott Park, IL.
Generic Name: paricalcitol
Brand Name: Zemplar
Synonyms: Zemplar